# Valsartan Versus Amlodipine Effect on Left Ventricular Multidirectional Deformation and Adipocytokines Level

Study · id `cardio:ct-nct03990480` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03990480](<https://clinicaltrials.gov/study/NCT03990480>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03990480

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 230 participants.

## Technical summary

Registry record NCT03990480. Randomized; no masking; primary purpose treatment. Start 2018-12-01 (actual); primary completion 2019-04-01 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 230 participants (enrolled count; ClinicalTrials.gov record NCT03990480, source copy `cardio:ctgov-nct03990480-2019-06-20`, retrieved 2026-10-26)
- Started: 2018-12-01 (actual) (ClinicalTrials.gov record NCT03990480, source copy `cardio:ctgov-nct03990480-2019-06-20`, retrieved 2026-10-26)
- Primary completion: 2019-04-01 (actual) (ClinicalTrials.gov record NCT03990480, source copy `cardio:ctgov-nct03990480-2019-06-20`, retrieved 2026-10-26)
- Completion: 2019-04-10 (actual) (ClinicalTrials.gov record NCT03990480, source copy `cardio:ctgov-nct03990480-2019-06-20`, retrieved 2026-10-26)
- Countries: Egypt (ClinicalTrials.gov record NCT03990480, source copy `cardio:ctgov-nct03990480-2019-06-20`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03990480-2019-06-20`, retrieved 2026-10-26)

## The registry's words

- Brief title: Valsartan Versus Amlodipine Effect on Left Ventricular Multidirectional Deformation and Adipocytokines Level
- Condition: Hypertension
- Intervention (Drug): valsartan (160 mg/d)
- Intervention (Drug): amlodipine (10 mg/d).
- Lead sponsor: Damanhour University
- Lead sponsor class: OTHER
- Collaborator: Tanta University
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: Damanhour University (`cardio:org-damanhour-university`)
- Registry lists this organization as a collaborator: Tanta University (`cardio:org-tanta-university`)

## Provenance

Content hash: f6085a3743c2594e8926c516ad9c1d0b0fed5d818edc8aa8a6846998b1fcc18e
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
